[18F]FDG-PET study in dementia with Lewy bodies and Alzheimer’s disease

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 25, Issue 2, 2001, Pages 447-456

  Okamura, Nobuyuki ^a   Arai, Hiroyuki ^a   Higuchi, Makoto ^a   Tashiro, Manabu ^a   Matsui, Toshifumi ^a   Hu, Xia Sheng ^a   Takeda, Atsushi ^b   Itoh, Masatoshi ^a   Sasaki, Hidetada ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alzheimer s disease; Familial dementia with Lewy bodies; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE SEVERITY; FAMILIAL DISEASE; FEMALE; HUMAN; LEWY BODY; MALE; METABOLIC DISORDER; OCCIPITAL CORTEX; POSITRON EMISSION TOMOGRAPHY; STATISTICAL PARAMETERS; VISUAL CORTEX; AGED; BRAIN; BRAIN MAPPING; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIFFUSE LEWY BODY DISEASE; GENETICS; IMAGE PROCESSING; MIDDLE AGED; NUCLEAR FAMILY; OCCIPITAL LOBE; PEDIGREE; REFERENCE VALUE; SCINTISCANNING;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; BRAIN MAPPING; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LEWY BODY DISEASE; MALE; MIDDLE AGED; NUCLEAR FAMILY; OCCIPITAL LOBE; PEDIGREE; RADIOPHARMACEUTICALS; REFERENCE VALUES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034745041     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(01)80005-1     Document Type: Article

References (19)

1. Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease
2. Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease
3. Cholinesterase inhibitors: A new class of psychotropic compounds
4. Spatial registration and normalization of images
5. Statistical maps in functional imaging: A general linear approach
6. Performance evaluation of a large axial field-of-view PET scanner: SET-2400W
7. Pathobiology of the Lewy body
8. Glucose hypometabolism and neuropathological correlates in brains in dementia with Lewy bodies
9. Mutation in the α-synuclein gene and sporadic Parkinson's disease, Alzheimer's disease and dementia with Lewy bodies
10. Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies
11. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease
12. Clinical features of familial diffuse Lewy body disease
13. Diffuse Lewy body disease in Japan
14. Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's disease
15. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
16. Diagnosing dementia with Lewy bodies
17. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under auspices of the Department of Health and Human Services Task Force on Alzheimer's disease
18. Cognitive decline is faster in Lewy body variant than in Alzheimer's disease
19. Autosomal dominant Lewy body Parkinsonism in a four-generation family